-
The American Society of Health-System Pharma-cists (ASHP) in Bethesda, MD, released in May a draft of the goals and objectives for pharmacy practice in health systems to be achieved by 2015.
-
Off-label use of a drug is common in health care, but pharmacists agree that they must minimize the risk by relying on their clinical judgment and the standard of care.
-
Zoledronic acid (Zometa) drug evaluation
-
-
The future of pharmacy practice has become a focus for one pharmacy group, and the reaction from members has been favorable and enthusiastic.
-
The U.S. Food and Drug Administration (FDA) has announced a new initiative to fight drug counterfeiters. As part of the initiative, an internal task force will look into technology and other measures including better education of pharmacists to try to stop counterfeit drugs from being distributed with or deliberately substituted for safe and effective drugs.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
Pharmacist shortage continues despite lower vacancies; Scholarship campaign launched to recruit pharmacy teachers; Warnings added to topiramate and somatropin; ASHP speaks out againstmarket access bill
-
-
The recognition of non-accidental injury is critical for a pediatric
trauma patient. In the year 2000, almost 3 million reports of child
abuse were made to social service agencies. Forty-four percent of the
fatalities were children younger than 1 year of age. Not only are these
statistics alarming, but they point out the need for emergency
department and trauma physicians and nurses to recognize non-accidental
injury and aggressively protect the children who seek our medical
expertise and protection.
